This marks the second consecutive year that the NP job has earned the top ranking in three categories. The Nursing Equity Assessment Tool can help nurses systematically and efficiently screen patients for complex care needs. The program provided a creative outlet for oncology nurses to reflect on and share their stories. Learn how oncology nurses can address patient questions about the withdrawal and help them navigate the path forward. Prithviraj Bose, MD, unpacks key highlights in MPN treatment and research at ASH 2024. Learn how these teleconsultations supported patients and helped increase clinic capacity. Amy Pierre, RN, BSN, ANP-BC, explains why it's important for advanced practice nurses to be invovled in research. Lisa Hwa, APRN, CNP, DNP, MS, is a member of the ASH Medical Educators Institute and has presented multiple ASH abstracts. Pierluigi Porcu, MD, discusses the phase II Tellomak trial and how nurses can help patients manage this rare disease. Amy Pierre, RN, BSN, ANP-BC, reflects on highlights from ASH 2024 and why it's critical for advanced practitioners to attend. An expert in pediatric GVHD shares his hopes and projections for the future of GVHD treatment and research. Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses the significance of ASH 2024. The CLL12 trial included patients with treatment-naive, asymptomatic, early-stage chronic lymphocytic leukemia. Amy Pierre, RN, BSN, ANP-BC, shares insights and key action items from her ASH 2024 presentation on the topic. Richard Newcomb, MD, shares insights from his ASH 2024 presentation and explains why nurses play a major role in outcomes. A group of nurses led development of a symptom management mobile app for patients recovering from breast surgery. Irwin Walker, MBBS, shares how he's seen the meeting evolve since his first time attending in 1971. Oncology nurses play a vital role in identifying the signs of treatment-related angiosarcoma during survivorship care. Theresa Brown, RN, weighs in on the public reaction to the shooting of United Healthcare CEO Brian Thompson. A researcher who will present on patient-reported outcomes and GVHD outcomes discusses the importance of the meeting.